Array
(
[id] => 162
[catid] => 78
[title] => European guidelines on perioperative venous thromboembolism prophylaxis Cardiovascular and thoracic surgery
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 1
[author] => 系统管理员
[status] => 9
[url] => /show/162.html
[link_id] => 0
[tableid] => 0
[inputip] => 14.105.95.222
[inputtime] => 2024-01-11 15:07:27
[updatetime] => 2024-01-11 15:07:27
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] => https://journals.lww.com/ejanaesthesiology/pages/articleviewer.aspx?year=2018&issue=02000&article=00003&type=Fulltext
[demo_url] =>
[zjpjff] => GRADE
[zjfj] =>
[tjqd] =>
[nianfen] => 2018
[guojia] => European Society of Anaesthesiology
[pdf] =>
[tjyjyw] =>
[lyyw] => In patients with severely impaired renal function (creatinine clearance <30 ml/min) and a high risk of haemorrhagic complications, we suggest close monitoring of the administration of therapeutic UFH and LMWH and adaptation of the dosage.（Evidence level:Low；Recommendation grade:Weak）
[laiyuan] => 对于肾功能严重受损（肌酐清除率＜30 ml/min）且出血性并发症风险较高的患者，我们建议密切监测治疗性 UFH 和 LMWH 的用药情况，并调整剂量。(证据质量：低；推荐强度：弱推荐)
[znzldj] => C
[_inputtime] => 1704956847
[_updatetime] => 1704956847
[_nrjc] =>
[_nrsh] =>
)
推荐意见
对于肾功能严重受损（肌酐清除率＜30 ml/min）且出血性并发症风险较高的患者，我们建议密切监测治疗性 UFH 和 LMWH 的用药情况，并调整剂量。(证据质量：低；推荐强度：弱推荐)
In patients with severely impaired renal function (creatinine clearance <30 ml/min) and a high risk of haemorrhagic complications, we suggest close monitoring of the administration of therapeutic UFH and LMWH and adaptation of the dosage.（Evidence level:Low；Recommendation grade:Weak）
证据评价方法：GRADE
指南质量等级：C
年份：2018
国家：European Society of Anaesthesiology
Array
(
[id] => 163
[catid] => 78
[title] => European guidelines on perioperative venous thromboembolism prophylaxis Cardiovascular and thoracic surgery
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 1
[author] => 系统管理员
[status] => 9
[url] => /show/163.html
[link_id] => 0
[tableid] => 0
[inputip] => 14.105.95.222
[inputtime] => 2024-01-11 15:07:27
[updatetime] => 2024-01-11 15:07:27
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] =>
[demo_url] =>
[zjpjff] => GRADE
[zjfj] =>
[tjqd] =>
[nianfen] => 2018
[guojia] => European Society of Anaesthesiology
[pdf] =>
[tjyjyw] =>
[lyyw] => UFH is associated with the highest risk of developing the pro-thrombotic condition of HIT. Therefore, in an attempt to minimise the risk of HIT, we suggest that UFH should be used as briefly as possible and replaced by LMWH as soon as the bleeding risk decreases（Evidence level:Low；Recommendation grade:Weak）
[laiyuan] => UFH（普通肝素）与发生 HIT（肝素诱发的血小板减少症）这种促血栓形成疾病的最高风险相关。因此，为了将HIT风险降至最低，我们建议应尽量缩短UFH的使用时间，并在出血风险降低后立即用 LMWH（低分子量肝素）替代。(证据质量：低，推荐强度：弱推荐)
[znzldj] => C
[_inputtime] => 1704956847
[_updatetime] => 1704956847
[_nrjc] =>
[_nrsh] =>
)
推荐意见
UFH（普通肝素）与发生 HIT（肝素诱发的血小板减少症）这种促血栓形成疾病的最高风险相关。因此，为了将HIT风险降至最低，我们建议应尽量缩短UFH的使用时间，并在出血风险降低后立即用 LMWH（低分子量肝素）替代。(证据质量：低，推荐强度：弱推荐)
UFH is associated with the highest risk of developing the pro-thrombotic condition of HIT. Therefore, in an attempt to minimise the risk of HIT, we suggest that UFH should be used as briefly as possible and replaced by LMWH as soon as the bleeding risk decreases（Evidence level:Low；Recommendation grade:Weak）
证据评价方法：GRADE
指南质量等级：C
年份：2018
国家：European Society of Anaesthesiology
Array
(
[id] => 164
[catid] => 78
[title] => European guidelines on perioperative venous thromboembolism prophylaxis Cardiovascular and thoracic surgery
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 1
[author] => 系统管理员
[status] => 9
[url] => /show/164.html
[link_id] => 0
[tableid] => 0
[inputip] => 14.105.95.222
[inputtime] => 2024-01-11 15:07:27
[updatetime] => 2024-01-11 15:07:27
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] =>
[demo_url] =>
[zjpjff] => GRADE
[zjfj] =>
[tjqd] =>
[nianfen] => 2018
[guojia] => European Society of Anaesthesiology
[pdf] =>
[tjyjyw] =>
[lyyw] => We suggest that low-dose aspirin could be used to decrease the incidence of VTE in cardiac and vascular patients but should not be considered as the sole agent in high-risk patients.（Evidence level:Low；Recommendation grade:Weak）
[laiyuan] => 建议使用小剂量阿司匹林来降低心脏和血管手术患者的 VTE 发生率，但不应将其作为高危患者的唯一药物。(证据质量：低；推荐强度：弱推荐)
[znzldj] => C
[_inputtime] => 1704956847
[_updatetime] => 1704956847
[_nrjc] =>
[_nrsh] =>
)
推荐意见
建议使用小剂量阿司匹林来降低心脏和血管手术患者的 VTE 发生率，但不应将其作为高危患者的唯一药物。(证据质量：低；推荐强度：弱推荐)
We suggest that low-dose aspirin could be used to decrease the incidence of VTE in cardiac and vascular patients but should not be considered as the sole agent in high-risk patients.（Evidence level:Low；Recommendation grade:Weak）
证据评价方法：GRADE
指南质量等级：C
年份：2018
国家：European Society of Anaesthesiology
Array
(
[id] => 165
[catid] => 78
[title] => European guidelines on perioperative venous thromboembolism prophylaxis Cardiovascular and thoracic surgery
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 1
[author] => 系统管理员
[status] => 9
[url] => /show/165.html
[link_id] => 0
[tableid] => 0
[inputip] => 14.105.95.222
[inputtime] => 2024-01-11 15:07:27
[updatetime] => 2024-01-11 15:07:27
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] =>
[demo_url] =>
[zjpjff] => GRADE
[zjfj] =>
[tjqd] =>
[nianfen] => 2018
[guojia] => European Society of Anaesthesiology
[pdf] =>
[tjyjyw] =>
[lyyw] => The presence of one or more risk factors [age above 70 years, transfusion of more than four units of RBC concentrate/fresh frozen plasma/cryoprecipitate/fibrinogen concentrate, mechanical ventilation more than 24 h, postoperative complication (e.g. acute kidney injury, infection/sepsis, neurological complication)] should place the cardiac population at high risk for VTE. In this context, we suggest the use of pharmacological prophylaxis as soon as satisfactory haemostasis has been achieved, in addition to IPC（Evidence level:Low；Recommendation grade:Weak）
[laiyuan] => 存在一个或多个风险因素[年龄超过 70 岁、输注超过 4 个单位的浓缩红细胞/新鲜冰冻血浆/干酪蛋白/浓缩纤维蛋白原、机械通气超过 24 小时、术后并发症（如急性肾损伤、感染/败血症、神经系统并发症）]应使心脏手术患者成为 VTE 的高危人群。在这种情况下，我们建议除 IPC（间歇性气压） 外，还应在止血满意后立即使用药物预防。(证据质量：低；推荐强度：弱推荐)
[znzldj] => C
[_inputtime] => 1704956847
[_updatetime] => 1704956847
[_nrjc] =>
[_nrsh] =>
)
推荐意见
存在一个或多个风险因素[年龄超过 70 岁、输注超过 4 个单位的浓缩红细胞/新鲜冰冻血浆/干酪蛋白/浓缩纤维蛋白原、机械通气超过 24 小时、术后并发症（如急性肾损伤、感染/败血症、神经系统并发症）]应使心脏手术患者成为 VTE 的高危人群。在这种情况下，我们建议除 IPC（间歇性气压） 外，还应在止血满意后立即使用药物预防。(证据质量：低；推荐强度：弱推荐)
The presence of one or more risk factors [age above 70 years, transfusion of more than four units of RBC concentrate/fresh frozen plasma/cryoprecipitate/fibrinogen concentrate, mechanical ventilation more than 24 h, postoperative complication (e.g. acute kidney injury, infection/sepsis, neurological complication)] should place the cardiac population at high risk for VTE. In this context, we suggest the use of pharmacological prophylaxis as soon as satisfactory haemostasis has been achieved, in addition to IPC（Evidence level:Low；Recommendation grade:Weak）
证据评价方法：GRADE
指南质量等级：C
年份：2018
国家：European Society of Anaesthesiology
Array
(
[id] => 166
[catid] => 78
[title] => European guidelines on perioperative venous thromboembolism prophylaxis Cardiovascular and thoracic surgery
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 1
[author] => 系统管理员
[status] => 9
[url] => /show/166.html
[link_id] => 0
[tableid] => 0
[inputip] => 14.105.95.222
[inputtime] => 2024-01-11 15:07:27
[updatetime] => 2024-01-11 15:07:27
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] =>
[demo_url] =>
[zjpjff] => GRADE
[zjfj] =>
[tjqd] =>
[nianfen] => 2018
[guojia] => European Society of Anaesthesiology
[pdf] =>
[tjyjyw] =>
[lyyw] => In the absence of risk factors, we suggest considering the risk of VTE as moderate in patients undergoing coronary artery by-pass graft (CABG) and bioprosthetic aortic valve implantation surgery. If theriskofbleedingistobeconsideredhigh, we suggest the use of mechanical prophylaxis using IPC.（Evidence level:Low；Recommendation grade:Weak）
[laiyuan] => 在没有风险因素的情况下，我们建议将接受冠状动脉旁路移植术（CABG）和生物人工主动脉瓣植入手术的患者的 VTE（静脉血栓栓塞）风险视为中度风险。如果出血风险被认为很高，我们建议使用 IPC（间歇性气压）进行机械预防。(证据质量：低；推荐强度：弱推荐)
[znzldj] => C
[_inputtime] => 1704956847
[_updatetime] => 1704956847
[_nrjc] =>
[_nrsh] =>
)
推荐意见
在没有风险因素的情况下，我们建议将接受冠状动脉旁路移植术（CABG）和生物人工主动脉瓣植入手术的患者的 VTE（静脉血栓栓塞）风险视为中度风险。如果出血风险被认为很高，我们建议使用 IPC（间歇性气压）进行机械预防。(证据质量：低；推荐强度：弱推荐)
In the absence of risk factors, we suggest considering the risk of VTE as moderate in patients undergoing coronary artery by-pass graft (CABG) and bioprosthetic aortic valve implantation surgery. If theriskofbleedingistobeconsideredhigh, we suggest the use of mechanical prophylaxis using IPC.（Evidence level:Low；Recommendation grade:Weak）
证据评价方法：GRADE
指南质量等级：C
年份：2018
国家：European Society of Anaesthesiology
Array
(
[id] => 167
[catid] => 48
[title] => European guidelines on perioperative venous thromboembolism prophylaxis Cardiovascular and thoracic surgery
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 1
[author] => 系统管理员
[status] => 9
[url] => /show/167.html
[link_id] => 0
[tableid] => 0
[inputip] => 14.105.95.222
[inputtime] => 2024-01-11 15:07:27
[updatetime] => 2024-01-11 15:07:27
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] =>
[demo_url] =>
[zjpjff] => GRADE
[zjfj] =>
[tjqd] =>
[nianfen] => 2018
[guojia] => European Society of Anaesthesiology
[pdf] =>
[tjyjyw] =>
[lyyw] => In high-risk patients, we suggest the use of pharmacological prophylaxis in addition to IPC.（Evidence level:Moderate；Recommendation grade:Weak）
[laiyuan] => 对于高危患者，我们建议在 IPC 的基础上使用药物预防（根据目前文献，在没有癌症的情况下接受胸部手术的患者可被视为 VTE 的低风险人群。然而，由于绝大多数接受胸腔手术的患者都确诊为原发性或转移性癌症，因此他们应被视为 VTE 的高危人群，出血风险同样很高。）(证据质量：中；推荐强度：弱推荐)
[znzldj] => C
[_inputtime] => 1704956847
[_updatetime] => 1704956847
[_nrjc] =>
[_nrsh] =>
)
推荐意见
对于高危患者，我们建议在 IPC 的基础上使用药物预防（根据目前文献，在没有癌症的情况下接受胸部手术的患者可被视为 VTE 的低风险人群。然而，由于绝大多数接受胸腔手术的患者都确诊为原发性或转移性癌症，因此他们应被视为 VTE 的高危人群，出血风险同样很高。）(证据质量：中；推荐强度：弱推荐)
In high-risk patients, we suggest the use of pharmacological prophylaxis in addition to IPC.（Evidence level:Moderate；Recommendation grade:Weak）
证据评价方法：GRADE
指南质量等级：C
年份：2018
国家：European Society of Anaesthesiology
Array
(
[id] => 128
[catid] => 100
[title] => Clinical Practice Guideline: Opioid Prescribing for Analgesia After Common Otolaryngology Operations Executive Summary
[thumb] =>
[keywords] =>
[description] =>
[hits] => 1
[uid] => 1
[author] => 系统管理员
[status] => 9
[url] => /show/128.html
[link_id] => 0
[tableid] => 0
[inputip] => 14.105.95.222
[inputtime] => 2024-01-11 15:07:26
[updatetime] => 2024-01-11 15:07:26
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 1
[wailian] => https://aao-hnsfjournals.onlinelibrary.wiley.com/doi/10.1177/0194599821996303
[demo_url] =>
[zjpjff] => GRADE
[zjfj] =>
[tjqd] =>
[nianfen] => 2021
[guojia] => AMERICAN ACADEMY OF HEAD AND NECK SURGERY
[pdf] =>
[tjyjyw] =>
[lyyw] => Clinicians should instruct patients and caregivers how to communicate if pain is not controlled or if medication side effects occur（Evidence level:Low；Recommendation grade:Recommendation）.
[laiyuan] => 临床医生应指导患者和护理人员如何在疼痛未得到控制或出现药物副作用时进行沟通。（证据级别：低 ；推荐强度：推荐）
[znzldj] => A
[_inputtime] => 1704956846
[_updatetime] => 1704956846
[_nrjc] =>
[_nrsh] =>
)
推荐意见
临床医生应指导患者和护理人员如何在疼痛未得到控制或出现药物副作用时进行沟通。（证据级别：低 ；推荐强度：推荐）
Clinicians should instruct patients and caregivers how to communicate if pain is not controlled or if medication side effects occur（Evidence level:Low；Recommendation grade:Recommendation）.
证据评价方法：GRADE
指南质量等级：A
年份：2021
国家：AMERICAN ACADEMY OF HEAD AND NECK SURGERY
Array
(
[id] => 129
[catid] => 100
[title] => Clinical Practice Guideline: Opioid Prescribing for Analgesia After Common Otolaryngology Operations Executive Summary
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 1
[author] => 系统管理员
[status] => 9
[url] => /show/129.html
[link_id] => 0
[tableid] => 0
[inputip] => 14.105.95.222
[inputtime] => 2024-01-11 15:07:26
[updatetime] => 2024-01-11 15:07:26
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] =>
[demo_url] =>
[zjpjff] => GRADE
[zjfj] =>
[tjqd] =>
[nianfen] => 2021
[guojia] => AMERICAN ACADEMY OF HEAD AND NECK SURGERY
[pdf] =>
[tjyjyw] =>
[lyyw] => Clinicians should promote shared decision making by informing patients of the benefits and risks of postoperative pain treatments that include nonopioid analgesics, opioid analgesics, and nonpharmacologic interventions（Evidence level:Low；Recommendation grade:Recommendation）.
[laiyuan] => 临床医生应告知患者术后疼痛治疗（包括非阿片类镇痛药、阿片类镇痛药和非药物干预）的益处和风险，从而促进共同决策。（证据级别：低 ；推荐强度：推荐）
[znzldj] => A
[_inputtime] => 1704956846
[_updatetime] => 1704956846
[_nrjc] =>
[_nrsh] =>
)
推荐意见
临床医生应告知患者术后疼痛治疗（包括非阿片类镇痛药、阿片类镇痛药和非药物干预）的益处和风险，从而促进共同决策。（证据级别：低 ；推荐强度：推荐）
Clinicians should promote shared decision making by informing patients of the benefits and risks of postoperative pain treatments that include nonopioid analgesics, opioid analgesics, and nonpharmacologic interventions（Evidence level:Low；Recommendation grade:Recommendation）.
证据评价方法：GRADE
指南质量等级：A
年份：2021
国家：AMERICAN ACADEMY OF HEAD AND NECK SURGERY
Array
(
[id] => 130
[catid] => 100
[title] => Clinical Practice Guideline: Opioid Prescribing for Analgesia After Common Otolaryngology Operations Executive Summary
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 1
[author] => 系统管理员
[status] => 9
[url] => /show/130.html
[link_id] => 0
[tableid] => 0
[inputip] => 14.105.95.222
[inputtime] => 2024-01-11 15:07:26
[updatetime] => 2024-01-11 15:07:26
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] =>
[demo_url] =>
[zjpjff] => GRADE
[zjfj] =>
[tjqd] =>
[nianfen] => 2021
[guojia] => AMERICAN ACADEMY OF HEAD AND NECK SURGERY
[pdf] =>
[tjyjyw] =>
[lyyw] => Prior to surgery, clinicians should advise patients and others involved in the postoperative care about the expected duration and severity of pain（Evidence level:Low；Recommendation grade:Recommendation）.
[laiyuan] => 手术前，临床医生应告知患者和其他术后护理人员预期疼痛的持续时间和严重程度。（证据分级：低 ；推荐强度：推荐）
[znzldj] => A
[_inputtime] => 1704956846
[_updatetime] => 1704956846
[_nrjc] =>
[_nrsh] =>
)
推荐意见
手术前，临床医生应告知患者和其他术后护理人员预期疼痛的持续时间和严重程度。（证据分级：低 ；推荐强度：推荐）
Prior to surgery, clinicians should advise patients and others involved in the postoperative care about the expected duration and severity of pain（Evidence level:Low；Recommendation grade:Recommendation）.
证据评价方法：GRADE
指南质量等级：A
年份：2021
国家：AMERICAN ACADEMY OF HEAD AND NECK SURGERY
Array
(
[id] => 131
[catid] => 101
[title] => Clinical Practice Guideline: Opioid Prescribing for Analgesia After Common Otolaryngology Operations Executive Summary
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 1
[author] => 系统管理员
[status] => 9
[url] => /show/131.html
[link_id] => 0
[tableid] => 0
[inputip] => 14.105.95.222
[inputtime] => 2024-01-11 15:07:26
[updatetime] => 2024-01-11 15:07:26
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] =>
[demo_url] =>
[zjpjff] => GRADE
[zjfj] =>
[tjqd] =>
[nianfen] => 2021
[guojia] => AMERICAN ACADEMY OF HEAD AND NECK SURGERY
[pdf] =>
[tjyjyw] =>
[lyyw] => In patients at risk for opioid use disorder(OUD), clinicians should evaluate the need to modify the analgesia plan（Evidence level:Low；Recommendation grade:Recommendation）.
[laiyuan] => 对于有阿片类药物使用禁忌的患者，临床医生应评估是否需要修改镇痛计划。（证据分级：低； 推荐强度：推荐）
[znzldj] => A
[_inputtime] => 1704956846
[_updatetime] => 1704956846
[_nrjc] =>
[_nrsh] =>
)
推荐意见
对于有阿片类药物使用禁忌的患者，临床医生应评估是否需要修改镇痛计划。（证据分级：低； 推荐强度：推荐）
In patients at risk for opioid use disorder(OUD), clinicians should evaluate the need to modify the analgesia plan（Evidence level:Low；Recommendation grade:Recommendation）.
证据评价方法：GRADE
指南质量等级：A
年份：2021
国家：AMERICAN ACADEMY OF HEAD AND NECK SURGERY
